Fragasso Financial Advisors Inc Purchases 20 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fragasso Financial Advisors Inc grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 687 shares of the medical equipment provider’s stock after buying an additional 20 shares during the quarter. Fragasso Financial Advisors Inc’s holdings in Intuitive Surgical were worth $359,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the 3rd quarter worth about $33,000. Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. DT Investment Partners LLC boosted its holdings in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the last quarter. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth approximately $37,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 1.4 %

Shares of ISRG opened at $539.75 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $355.17 and a 12-month high of $556.23. The company has a market capitalization of $192.25 billion, a PE ratio of 86.78, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The business’s 50 day moving average is $536.58 and its 200 day moving average is $495.83.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Truist Financial boosted their price target on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Finally, Leerink Partners increased their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.